Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Iloprost
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ventavis 10micrograms/ml nebuliser solution 1ml ampoules
0205010V0BBAAAC
|
Ventavis | Iloprost | Cardiovascular System | 4 |
|
Iloprost 10micrograms/1ml nebuliser liquid ampoules
0205010V0AAACAC
|
Iloprost | Iloprost | Cardiovascular System | 2 |
|
Ilomedin 100micrograms/1ml solution for infusion ampoules
0205010V0BCAAAA
|
Ilomedin | Iloprost | Cardiovascular System | No data available |
|
Iloprost 100micrograms/1ml solution for infusion ampoules
0205010V0AAAAAA
|
Iloprost | Iloprost | Cardiovascular System | No data available |
|
Iloprost 10micrograms/1ml neb liq ampoules with device
0205010V0AAAEAE
|
Iloprost | Iloprost | Cardiovascular System | No data available |
|
Iloprost 20micrograms/1ml neb liq ampoules with device
0205010V0AAAFAF
|
Iloprost | Iloprost | Cardiovascular System | No data available |
|
Iloprost 20micrograms/1ml nebuliser liquid ampoules
0205010V0AAADAD
|
Iloprost | Iloprost | Cardiovascular System | No data available |
|
Iloprost 50micrograms/0.5ml solution for infusion ampoules
0205010V0AAABAB
|
Iloprost | Iloprost | Cardiovascular System | No data available |
|
Ventavis 10micrograms/ml neb soln 1ml ampoules with Breelib
0205010V0BBACAE
|
Ventavis | Iloprost | Cardiovascular System | No data available |
|
Ventavis 20micrograms/ml neb soln 1ml ampoules with Breelib
0205010V0BBADAF
|
Ventavis | Iloprost | Cardiovascular System | No data available |
|
Ventavis 20micrograms/ml nebuliser solution 1ml ampoules
0205010V0BBABAD
|
Ventavis | Iloprost | Cardiovascular System | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.